January Therapeutics is developing next generation targeted anti-cancer therapies. 

Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties. 

Biotechnology

January Therapeutics

Thomas B. Broudy

Norman (Norm) Herman

Norm Herman

Jason Kahana

Jackie Walling

Don Rindell

The executive team at January Therapeutics has a history of working in the pharmaceutical industry and consulting on drug development. They have also been educated in the fields of biology and medicine.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at January Therapeutics

Board of Directors

Leadership Team